Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Genes from a gene cluster

a gene cluster and gene technology, applied in the field of gene clusters, can solve the problems of insufficient molecular biological analysis into the biosynthesis of ml-236b, and factors regulating

Inactive Publication Date: 2005-09-29
SANKYO CO LTD
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a polynucleotide that can speed up the production of a specific chemical called ML-236B. This polynucleotide is a protein-encoding sequence that can be modified by adding, deleting, substituting, or altering certain amino acids. The technical effect of this invention is to provide a tool for increasing the efficiency of producing a specific chemical compound.

Problems solved by technology

However, to date, there has been insufficient molecular biological analysis into the biosynthesis of ML-236B, and factors regulating it.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Genes from a gene cluster
  • Genes from a gene cluster
  • Genes from a gene cluster

Examples

Experimental program
Comparison scheme
Effect test

example 1

Construction of pSAKcos1 Vector

[0165] Plasmid pSAK333 containing the hygromycin B phosphotransferase gene (hereinafter referred to as “HPT”) originating from Escherichia coli (Japanese Patent Application Publication No. 3-262486) was digested with restriction enzyme BamHI (manufactured by Takara Shuzo Co., Ltd., Japan), and was treated to form blunt ends with T4DNA polymerase (manufactured by Takara Shuzo Co., Ltd., Japan).

[0166] The DNA fragment obtained as above was self-ligated into a circular form using DNA ligation kit Ver.2 (manufactured by Takara Shuzo Co., Ltd., Japan), and competent cells JM 109 of Escherichia coli (manufactured by Takara Shuzo Co., Ltd., Japan) were then transformed therewith. A strain having a plasmid in which the BamHI site was deleted was selected from the transformed Escherichia coli, and was designated pSAK360.

[0167] pSAK 360 was digested with restriction enzyme PvuII, and then treated with alkaline phosphatase to produce a fragment dephosphorylate...

example 2

Preparation of Genomic DNA of Penicillium citrinum SANK 13380

1) Culture of Penicillium citrinum SANK 13380

[0170] A seed culture of Penicillium citrinum SANK 13380 was made on a slant of PGA agar medium. Namely, the agar was inoculated with Penicillium citrinum SANK 13380 using a platinum needle, and kept at 26° C. for 14 days. The slant was kept at 4° C.

[0171] Main culturing was performed by liquid aeration culture. Cells from a 5 mm square of the above-mentioned slant were inoculated in 50 ml of MBG3-8 medium in 500 ml conical flask, and incubated at 26° C. with shaking at 210 rpm for five days.

2) Preparation of Genomic DNA from Penicillium citrinum SANK 13380

[0172] The culture obtained in step 1) was centrifuged at 10000×G at room temperature for 10 minutes, and cells were harvested. 3 g (wet weight) of cells were broken in a mortar cooled with dry ice so as to be in the form of a powder. The broken cells were put in a centrifuge tube filled with 20 ml of 62.5 mM EDTA 2Na (...

example 3

Preparation of Genomic DNA Library of Penicillium citrinum SANK13380

1) Preparation of Genomic DNA Fragment

[0176] 0.25 units of Sau3A1 (Takara Shuzo Co., Ltd., Japan) were added to 100 μl of an aqueous solution of genomic DNA (50 μg) of Penicillium citrinum SANK13380 obtained in Example 2. After intervals of 10, 30, 60, 90 and 120 seconds, 20 μl samples of the mixture were taken, and 0.5 M EDTA (pH 8.0) was added to each sample to terminate the restriction enzyme reaction. The resulting partially digested DNA fragments were separated by agarose gel electrophoresis, and agarose gel was recovered containing DNA fragments of 30 kb or more

[0177] The recovered gel was finely crushed, and placed into Ultra Free C3 Centrifuged Filtration Unit (manufactured by Japan Milipore corporation). The gel was cooled at −80° C. for 15 minutes until frozen, and then the gel was melted by incubating it at 37° C. for 10 minutes. It was centrifuged at 5000×G for 5 minutes, to extract DNA. The DNA was ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
wavelengthaaaaaaaaaa
wavelengthaaaaaaaaaa
Login to View More

Abstract

ML-236B is an inhibitor of HMG-CoA reductase and useful in preparing another such inhibitor, pravastatin. The preparation of ML-236B using an ML-236B-producing microorganism is enhanced using a polynucleotide encoding a gene related to the polyketide synthase cluster occurring in such a microorganism.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a Divisional application of application Ser. No. 09 / 836,705 filed Apr. 17, 2001.FIELD OF THE INVENTION [0002] The present invention relates to a gene cluster, and more particularly to genes from a gene cluster. [0003] More particularly the invention relates to polynucleotides, such as DNA, which accelerate the biosynthesis of a HMG-CoA reductase inhibitor, ML-236B, in an ML-236B producing micro-organism when introduced in the ML-236B producing micro-organism. The invention further relates to vector into which said polynucleotides are incorporated, host cells transformed by said vectors, proteins expressed by said vectors, a method for producing ML-236B using said polynucleotides and / or proteins when the method comprises recovering ML-236B from the culture of said host cell, and the invention further relates to other associated aspects. BACKGROUND OF THE INVENTION [0004] Pravastatin is an HMGCoA reductase inhibitor. Pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/385C12N1/21C12N15/52C12P17/06C12P17/18C12R1/19
CPCC07K14/385C12N15/52C12P17/181C12P7/62C12P17/06C12P7/42C12N15/11
Inventor ABE, YUKIONO, CHIHOYOSHIKAWA, HIROJI
Owner SANKYO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com